Presentation is loading. Please wait.

Presentation is loading. Please wait.

Proline supplementation during P5CS protein knockdown suppressed GCN2 activation. Proline supplementation during P5CS protein knockdown suppressed GCN2.

Published byDwayne Harris Modified over 5 years ago

Similar presentations

Presentation on theme: "Proline supplementation during P5CS protein knockdown suppressed GCN2 activation. Proline supplementation during P5CS protein knockdown suppressed GCN2."— Presentation transcript:

1 Proline supplementation during P5CS protein knockdown suppressed GCN2 activation.
Proline supplementation during P5CS protein knockdown suppressed GCN2 activation. Melanoma cell lines UACC 903, 1205 Lu, and A375M were transfected with siRNA-targeting ALDH18A1 or a scrambled control siRNA. Cells were maintained in 1.25 mmol/L (UACC 903, A375M) or 2.5 mmol/L (1205 Lu) proline media for 48 or 96 hours before collecting protein lysates. Western blotting compared phosphorylated with total protein levels. Protein band intensity was quantified using ImageJ software, normalized to ERK2 loading control, and expressed as a percentage of the scrambled siRNA blot intensity. Gregory R. Kardos et al. Mol Cancer Res 2015;13: ©2015 by American Association for Cancer Research

Download ppt "Proline supplementation during P5CS protein knockdown suppressed GCN2 activation. Proline supplementation during P5CS protein knockdown suppressed GCN2."

Similar presentations

Enhanced DNA damage in IDH1 mutant glioma cells.

Enhanced DNA damage in IDH1 mutant glioma cells.
Rab11-FIP3 silencing upregulates TCR-CD3 cell surface expression in an Lck-dependent manner. Rab11-FIP3 silencing upregulates TCR-CD3 cell surface expression.

Rab11-FIP3 silencing upregulates TCR-CD3 cell surface expression in an Lck-dependent manner. Rab11-FIP3 silencing upregulates TCR-CD3 cell surface expression.
Downregulation of SPRY4 expression is associated with FGFR1–FRS2 activation. Downregulation of SPRY4 expression is associated with FGFR1–FRS2 activation.

Downregulation of SPRY4 expression is associated with FGFR1–FRS2 activation. Downregulation of SPRY4 expression is associated with FGFR1–FRS2 activation.
Interfering with HMGA2 expression blocks transformation in metastatic lung cancer cells. Interfering with HMGA2 expression blocks transformation in metastatic.

Interfering with HMGA2 expression blocks transformation in metastatic lung cancer cells. Interfering with HMGA2 expression blocks transformation in metastatic.
Collagen-dependent phosphorylation of eIF4E in PDAC cells.

Collagen-dependent phosphorylation of eIF4E in PDAC cells.
Effect of Nf1 knockdown on Wnt pathway in MSC80 cells.

Effect of Nf1 knockdown on Wnt pathway in MSC80 cells.
AMPK induces VEGF-A production by upregulating ERK signaling.

AMPK induces VEGF-A production by upregulating ERK signaling.
ONC201 activates the ATF4 pathway through the eIF2α kinases HRI and PKR. ONC201 activates the ATF4 pathway through the eIF2α kinases HRI and PKR. (A) Western.

ONC201 activates the ATF4 pathway through the eIF2α kinases HRI and PKR. ONC201 activates the ATF4 pathway through the eIF2α kinases HRI and PKR. (A) Western.
HIPK2 decreases the stability of Notch1-IC through proteasome-dependent degradation. HIPK2 decreases the stability of Notch1-IC through proteasome-dependent.

HIPK2 decreases the stability of Notch1-IC through proteasome-dependent degradation. HIPK2 decreases the stability of Notch1-IC through proteasome-dependent.
eIF5A-PEAK1 signaling regulates KRAS protein expression.

eIF5A-PEAK1 signaling regulates KRAS protein expression.
Titration of antisera against the amount of extract loaded on Western blots. Titration of antisera against the amount of extract loaded on Western blots.

Titration of antisera against the amount of extract loaded on Western blots. Titration of antisera against the amount of extract loaded on Western blots.
Knocking down Wnt3 increases the cells' response to trastuzumab and reduces cells' invasiveness. Knocking down Wnt3 increases the cells' response to trastuzumab.

Knocking down Wnt3 increases the cells' response to trastuzumab and reduces cells' invasiveness. Knocking down Wnt3 increases the cells' response to trastuzumab.
JAK3A572V mutation causes constitutive JAK3 activity and IL-2–independent proliferation of NKTCL cells. JAK3A572V mutation causes constitutive JAK3 activity.

JAK3A572V mutation causes constitutive JAK3 activity and IL-2–independent proliferation of NKTCL cells. JAK3A572V mutation causes constitutive JAK3 activity.
BCL-3 regulates expression of stemness-associated Wnt targets.

BCL-3 regulates expression of stemness-associated Wnt targets.
eNOS regulated IR-induced NO generation and EGFR signal activation.

eNOS regulated IR-induced NO generation and EGFR signal activation.
Lats2 functions at the G1–S checkpoint in U2OS cells.

Lats2 functions at the G1–S checkpoint in U2OS cells.
co-IP of LEDGF/p75 and MeCP2.

co-IP of LEDGF/p75 and MeCP2.
Targeting eIF4E increases ZEB1 protein and mRNA levels and decreases ZEB1-targeting miR-200c and miR-141 microRNAs. Targeting eIF4E increases ZEB1 protein.

Targeting eIF4E increases ZEB1 protein and mRNA levels and decreases ZEB1-targeting miR-200c and miR-141 microRNAs. Targeting eIF4E increases ZEB1 protein.
TFAP2A interacts with HIF-1α and regulates VEGF expression and cell proliferation. TFAP2A interacts with HIF-1α and regulates VEGF expression and cell.

TFAP2A interacts with HIF-1α and regulates VEGF expression and cell proliferation. TFAP2A interacts with HIF-1α and regulates VEGF expression and cell.
A, IGFBP-3 knockdown via siRNA using real-time qRT-PCR analysis.

A, IGFBP-3 knockdown via siRNA using real-time qRT-PCR analysis.

Similar presentations

Ads by Google